Abstract:Introduction: The N-terminal domain of angiopoietin-like protein 3 (ANGPTL3) inhibits lipoprotein lipase activity. Its C-terminal fibrinogen-like (FBN) domain is a ligand of macrophage integrin αvβ3. Objectives: ANGPTL3 might home to plaque where it directly regulates macrophage function via integrin αvβ3 for atherosclerosis progression. Methods: Ldlr-/- mice on a high-fat diet and ApoE-/- mice on a chow diet were received adeno-associated virus (AAV)-mediated Angptl3 gene transfer and followed up for 12 weeks. ApoE-/- mice were injected AAV containing FLAG-tagged Angptl3 cDNA for tracing. Atherosclerotic features were compared between Angptl3-/-ApoE-/- mice and ApoE-/- littermates. THP-1 cells were exposed to 0 or 50 μg/ml ANGPTL3 FBN domain for 24 h to evaluate Toll-like receptor (TLR)4 expression using western blot analysis and circulating cytokine and chemokine profiles by the MILLIPLEX MAP assay. Phospho-proteomic profile was established in ANGPTL3-treated macrophages. Integrin β3 deficient THP-1 cells were obtained by sgRNAs targeting RGD sequence using Lentivirus-Cas9 system. Results: Angptl3 overexpression increased atherosclerotic progression and CD68+ macrophages in plaque (p < 0.05 for all). By immunostaining, FLAG+ cells were identified in plaque of gene transferred ApoE-/- mice. Fluorescent immunostaining detected co-localisation of Angptl3 and CD68 in plaque macrophages. Phospho-proteomic analysis revealed that Angptl3 induced phosphorylation of proteins that were involved in the IL-17 signalling pathway in THP-1 cells. In vitro, ANGPTL3 treatment increased the production of interleukin (IL)-1β and tumour necrosis factor-α in THP-1 cells (p < 0.05 for both). Exposure of ANGPTL3 to THP-1 cells induced Akt phosphorylation which was weakened in integrin β3 deficient ones. ANGPTL3 elevated TLR4 expression via Akt phosphorylation. In response to lipopolysaccharide, nuclear factor-κB activity was 2.2-fold higher in THP-1 cells pre-treated with ANGPTL3 than in untreated cells (p < 0.05). Conclusions: Targeting ANGPTL3 could yield a dual benefit of lowering lipid levels in the blood and suppressing macrophage activation in plaque.

FSTL3 Induces Lipid Accumulation and Inflammatory Response in Macrophages and Associates with Atherosclerosis.

FSTL3 is Highly Expressed in Adipose Tissue of Individuals with Overweight or Obesity and is Associated with Inflammation

miR-125a-3p regulates the expression of FSTL1, a pro-inflammatory factor, during adipogenic differentiation, and inhibits adipogenesis in mice

Follistatin-like 1 and inflammatory responses of diabetic atherosclerosis

Follistatin‐like Protein 1 (FSTL1) Promotes Chondrocyte Expression of Matrix Metalloproteinase and Inflammatory Factors Via the NF‐κB Pathway

Follistatin-Like 1: A Potential Mediator Of Inflammation In Obesity

FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2

Molecular Mechanism of Oxldl Inducing Lipid Accumulation and Inflammation in Macrophages to Promot Atherosclerosisvia TLR4 Signaling Pathway

Intracellular-free calcium dynamics and F-actin alteration in the formation of macrophage foam cells.

ANGPTL3 accelerates atherosclerotic progression via direct regulation of M1 macrophage activation in plaque

Follistatin Like Protein-1 Modulates Macrophage Polarization and Aggravates Dextran Sodium Sulfate-Induced Colitis.

Interleukin-36γ aggravates macrophage foam cell formation and atherosclerosis progression in ApoE knockout mice

Abstract 9816: Clinical and Pathophysiological Relevance of Follistatin-Like 1 in Calcific Aortic Valve Disease

Follicle-Stimulating Hormone Provokes Macrophages to Secrete IL-1b Contributing to Atherosclerosis Progression

ILF3 is responsible for hyperlipidemia-induced arteriosclerotic calcification by mediating BMP2 and STAT1 transcription

FAM3A mediates the phenotypic switch of human aortic smooth muscle cells stimulated with oxidised low-density lipoprotein by influencing the PI3K-AKT pathway

Macrophage-derived FGFR1 drives atherosclerosis through PLCγ-mediated activation of NF-κB inflammatory signaling pathway

Identification of the Transcription Factor ATF3 as a Direct and Indirect Regulator of the LDLR

Follicle-Stimulating Hormone Provokes Macrophages to Secrete IL-1β Contributing to Atherosclerosis Progression.

Angiocrine FSTL1 (Follistatin-Like Protein 1) Insufficiency Leads to Atrial and Venous Wall Fibrosis Via SMAD3 Activation

The Effect and Mechanism of TLR9/KLF4 in FFA-Induced Adipocyte Inflammation